NEEDS ASSESSMENT AND SYMPOSIUM GOAL

The focus of this year’s symposium is to update the psychiatric, medical and mental health communities on key issues in patient management. 

The majority of mental health services are delivered in the primary care setting, where depression and anxiety are among the conditions most commonly diagnosed.  Sleep disturbances are a very common concern among practitioners of all disciplines.  Of even greater concern is the fact that there are many persons suffering from sleep disorders who never receive treatment. This activity will offer practitioners new available treatment options.

Finally, the systematic study of the relationship between female reproductive biology and risk for mood disturbance in childbearing women as well as in peri and postmenopausal women has recently received increasing attention.  With additional knowledge, physicians will be better able to identify these patients and the most appropriate therapeutic interventions will minimize the morbidity and suffering associated with affective disorders.

EDUCATIONAL OBJECTIVES

After completing this activity, the participant should be able to:

TARGET AUDIENCE

This activity has been designed to meet the educational needs of psychiatrists, primary care physicians and other healthcare providers interested in acquiring additional knowledge concerning psychiatric disorders in the patient population.

ACCREDITATION AND CREDITS

EXCEL Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

EXCEL Continuing Education designates this educational activity for a maximum of four AMA PRA Category 1 Credits™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.

FACULTY DISCLOSURE STATEMENT

As a provider accredited by the ACCME, it is the policy of EXCEL Continuing Education to require disclosure of the existence of any significant financial interest or any other relationship the faculty members have with the manufacturer(s) of any commercial product(s) discussed in an educational presentation.  Any discussions of unlabeled/unapproved uses of drugs or devices will be disclosed to the audience prior to the activity.  Full disclosure will be made in the course materials.